Interim Report of the Reactogenicity and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 XBB–Containing Vaccines
Chalkias, Spyros, McGhee, Nichole, Whatley, Jordan L, Essink, Brandon, Brosz, Adam, Tomassini, Joanne E, Girard, Bethany, Edwards, Darin K, Wu, Kai, Nasir, Arshan, Lee, Diana, Avena, Laura E, Feng, Jing, Deng, Weiping, Montefiori, David C, Baden, Lindsey R, Miller, Jacqueline M, Das, Rituparna
Published in The Journal of infectious diseases (16.08.2024)
Published in The Journal of infectious diseases (16.08.2024)
Get full text
Journal Article
Original SARS-CoV-2 monovalent and Omicron BA.4/BA.5 bivalent COVID-19 mRNA vaccines: phase 2/3 trial interim results
Chalkias, Spyros, Whatley, Jordan L., Eder, Frank, Essink, Brandon, Khetan, Shishir, Bradley, Paul, Brosz, Adam, McGhee, Nichole, Tomassini, Joanne E., Chen, Xing, Zhao, Xiaoping, Sutherland, Andrea, Shen, Xiaoying, Girard, Bethany, Edwards, Darin K., Feng, Jing, Zhou, Honghong, Walsh, Stephen, Montefiori, David C., Baden, Lindsey R., Miller, Jacqueline M., Das, Rituparna
Published in Nature medicine (01.09.2023)
Published in Nature medicine (01.09.2023)
Get full text
Journal Article